Please assess the completion status of the following clinical trial:

Trial Title: Low and High Dose Dextrose Prolotherapy in the Treatment of Lateral Epicondylitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SEQUENTIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Those who admit Kirsehir Ahi Evran University Hospital and is diagnosed with lateral epicondylitis,~* Participants with unilateral or bilateral lateral epicondylitis and pain and functional limitations due to this condition,~* who can read and write in Turkish,~* participant's admission participating in the study,~* participants who do not have exclusion criteria,~Exclusion Criteria:~* receiving any injection therapy to the elbow area in the last 3 months,~* participants with complaints less than 3 months(acute lateral epicondylitis)~* previously surgery on the elbow area,~* having a history of acute trauma or fracture in the elbow area,~* have local dermatological problems,~* have a local infection in the treatment area,~* those who are allergic to dextrose,~* with coagulation disorders or using anticoagulant drugs,~* with an autoimmune disease,~* with type 1 or type 2 diabetes mellitus,~* have unregulated hypertension,~* have immune dysfunction,~* with malignancy or diagnosed with a malignancy in the last 5 years,~* pregnancy or lactation,~* having cervical radiculopathy in the same extremity,~* with cognitive dysfunction,~* patients with paralysis in the same extremity,~* lack of cooperation due to cognitive impairment,~* participant's refusal to participate in the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- low dose dextrose arm (5% dextrose) (Type: ACTIVE_COMPARATOR): Prolotherapy injection will be made with 5% dextrose solution for 3 sessions with 3 weeks intervals. 1ml solution will be given with 27 Gauge 1/2 inch needles in the sessions. Before the treatment, the examination and questionnaire data of the patient will be recorded.
- high dose dextrose arm (15% dextrose) (Type: ACTIVE_COMPARATOR): Prolotherapy injection will be made with 15% dextrose solution for 3 sessions with 3 weeks intervals. 1ml solution will be given with 27 Gauge 1/2 inch needles in the sessions. Before the treatment, the examination and questionnaire data of the patient will be recorded.
- Isotonic saline arm (0.9% NaCl) (Type: ACTIVE_COMPARATOR): Prolotherapy injection will be made with isotonic saline for 3 sessions with 3 weeks intervals. 1ml solution will be given with 27 Gauge 1/2 inch needles in the sessions. Before the treatment, the examination and questionnaire data of the patient will be recorded.

Based on this trial design, predict the completion outcome and termination type (if applicable).